Drugs / Flublok Quadrivalent vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03617523 | Sep → Nov 2018 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flublok Quadrivalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03617523 ↗ |
| Modality | Vaccine | “Flublok Quadrivalent vaccine, 2018-2019 formulation” NCT03617523 ↗ |
| Route | Intramuscular | “Route of administration: Intramuscular” NCT03617523 ↗ |